Rocket Pharmaceuticals jumps 16.8% as FDA grants RMAT status to RP-A601 on positive phase I heart disease data.

TAP leans into premium brands like Peroni and Madri to lift margins. Yet, volume declines remain a hurdle.

Shelagh Glaser, CFO of Synopsys (SNPS), talks about the company's recent acquisition of Ansys. She believes it will make Synopsys a leading engineer for silicon design and software security.

RANCHO CORDOVA, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the "Bank"), announced today the declaration of a cash dividend of $0.20 per share on the Company's voting common stock. The dividend is expected to be paid on August 11, 2025, to shareholders of record as of August 4, 2025.

The company filed a statement with the SEC to change the structure of its flagship QQQ ETF.

INOD rides Gen AI momentum with major Big Tech deals and a 40% revenue growth forecast, but high valuation raises caution.

GOOGL's second-quarter 2025 results are likely to reflect strength in Generative AI, Search, and Cloud amid rising cloud competition and stretched valuation.

HBAN's Q2 EPS rises to 38 cents, matching estimates, as NII climbs 12% despite higher costs and weaker fee income.

RADNOR, Pa., July 18, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS) on behalf of those who purchased or otherwise acquired Hims & Hers securities between April 29, 2025, and June 23, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is August 25, 2025.

Cohen & Steers, Inc. (NYSE:CNS ) Q2 2025 Earnings Conference Call July 18, 2025 10:00 AM ET Company Participants Brian William Heller - Senior VP & Corporate Counsel Jon Young Cheigh - President & Chief Investment Officer Joseph Martin Harvey - CEO & Director Raja Adnan Dakkuri - Executive VP & CFO Conference Call Participants John Joseph Dunn - Evercore ISI Institutional Equities, Research Division Rodrigo Beisbier Ferreira - BofA Securities, Research Division Operator Ladies and gentlemen, thank you for standing by. Welcome to the Cohen & Steers Second Quarter 2025 Earnings Conference Call.

Ally Financial Inc. (NYSE:ALLY ) Q2 2025 Earnings Conference Call July 18, 2025 9:00 AM ET Company Participants Michael G. Rhodes - CEO & Director Russell E.

Transaction in Own Shares 18 July, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 18 July, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 18/07/2025 558,993 £26.4700 £26.2050 £26.3539 LSE GBP 18/07/2025 174,866 £26.4750 £26.2350 £26.3576 Chi-X (CXE) GBP 18/07/2025 96,141 £26.4750 £26.2400 £26.3622 BATS (BXE) GBP 18/07/2025 492,509 €30.7250 €30.3650 …

INTU bets big on AI with GenOS and virtual agents, driving faster workflows, smarter insights and rising revenues.

GDOT's low 7.99X forward P/E hints at value, but investors are watching liquidity and strategic moves closely.

July 18, 2025 – TheNewswire - Montreal, Quebec - Canada Beauce Gold Fields (Champs D'Or en Beauce) (TSX Venture: "BGF"), referred to as "BGF" or the "Company," a mineral exploration company focused on gold in southern Quebec, is proud to have attended the official inauguration of the Promenade des Mines and the Séraphin-Bolduc Dredge historic site on July 11, 2025. Hosted by the Municipality of Saint-Simon-les-Mines, the event celebrated the town's mining heritage and the revitalization of the community's historical landmarks. As part of its commitment to preserving local heritage, BGF made a symbolic donation to the municipality, consisting of …

NVR's second-quarter 2025 performance is likely to have reflected softer-than-anticipated demand and higher expenses.

Tyler Technologies, Inc. has strong organic growth, a large public sector customer base, and significant cross-selling and payment market opportunities. The company's SaaS transition and recurring revenue model are driving margin expansion, with impressive recent financial results and robust project pipelines. Despite these positives, I find TYL stock significantly overvalued, justifying my continued Strong Sell rating and a fair value estimate of $339 per share.

JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.

Jason Helfstein, Oppenheimer senior internet analyst, joins 'Money Movers' to discuss his takeaways from Netflix's q2 earnings.

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action.